BIOTECHNOLOGY

Precisio Biotix Therapeutics, Inc. (Precisio) Announces the Use of Its ClyO (Staph Lysin) to Treat a Multi Drug-Resistant Prosthetic Joint Infection (PJI) Under an Expanded Access Chronic Care Management Protocol

Lysins are a promising new family of enzyme-based antimicrobials which [...]

By |2026-07-10T15:14:25+00:00July 10, 2026|3rd Party Medical Device Industry News|Comments Off on Precisio Biotix Therapeutics, Inc. (Precisio) Announces the Use of Its ClyO (Staph Lysin) to Treat a Multi Drug-Resistant Prosthetic Joint Infection (PJI) Under an Expanded Access Chronic Care Management Protocol
Go to Top